Camptodactyly, tall stature, and hearing loss syndrome

Last updated
Camptodactyly-tall stature-hearing loss syndrome
Other namesCATSHL syndrome
Camptodactyly-tall stature-hearing loss syndrome.png
Specialty Medical genetics
Symptoms camptodactyly, hearing loss and tall height
Complications hearing impairment
Usual onsetbirth
Durationlife-long
Causes Genetic mutation
Diagnostic method physical examination, genetic testing
Preventionnone
Prognosis good
Frequencyvery rare, only 30 cases have been documented in medical literature

Camptodactyly, tall stature, and hearing loss syndrome, also known as CATSHL syndrome, [1] is a rare genetic disorder which consists of camptodactyly, tall height, scoliosis, and hearing loss. Occasionally, developmental delay and intellectual disabilities are reported. About 30 (live) people with the disorder have been recorded in medical literature to date (May 2022); 27 people from a four-generation Utah family and 2 brothers from consanguineous Egyptian parents. [2] [3] This disorder is caused by autosomal dominant (rarely recessive) missense mutations in the FGFR3 gene. [4] [5] [6] [7] [8] [9]

Contents

Symptoms

The main symptoms of this disease are: [10] [7]

Occasionally: [3]

Cause

CASTHL syndrome is caused by a dominant loss-of-function missense mutation of FGFR3 gene. [3]

It is known that FGFR3 negatively regulates bone growth through negative regulation of endochondral ossification mechanism. [11] In this disease this mechanism is disrupted. [12]

Diagnosis

CATSHL syndrome diagnosis can be suspected by phenotype, subsequently diagnosis can be confirmed by genetic testing. [13]

Treatment

This disease doesn’t have a cure, although symptomatic management is available. [14]

Prognosis

Prognosis is good, because death cases because of that disease hadn’t been identified. [3] [5]

History

The mutation in mice that causes CATSHL-like symptoms was described by Colvin et al in 1996. [12] First human cases have been reported by Toydemir et al in 2006 in a large Utah family. [5]

Prevalence

The frequency of that disease is unknown, although 30 cases have been recorded. [15]

References

  1. "Camptodactyly, tall stature, and hearing loss syndrome". NORD (National Organization for Rare Disorders). Retrieved 2022-05-15.
  2. "OMIM Entry - # 610474 - Camptodactyly, Tall Stature, and Hearing Loss Syndrome; CATSHLS". omim.org. Retrieved 2022-05-15.
  3. 1 2 3 4 Makrythanasis, Periklis; Temtamy, Samia; Aglan, Mona S.; Otaify, Ghada A.; Hamamy, Hanan; Antonarakis, Stylianos E. (August 2014). "A novel homozygous mutation in FGFR3 causes tall stature, severe lateral tibial deviation, scoliosis, hearing impairment, camptodactyly, and arachnodactyly". Human Mutation. 35 (8): 959–963. doi: 10.1002/humu.22597 . ISSN   1098-1004. PMID   24864036. S2CID   22570252.
  4. "Camptodactyly, tall stature, and hearing loss syndrome - About the Disease - Genetic and Rare Diseases Information Center". rarediseases.info.nih.gov. Archived from the original on January 8, 2017. Retrieved 2022-05-15.
  5. 1 2 3 Toydemir, Reha M.; Brassington, Anna E.; Bayrak-Toydemir, Pinar; Krakowiak, Patrycja A.; Jorde, Lynn B.; Whitby, Frank G.; Longo, Nicola; Viskochil, David H.; Carey, John C.; Bamshad, Michael J. (November 2006). "A novel mutation in FGFR3 causes camptodactyly, tall stature, and hearing loss (CATSHL) syndrome". American Journal of Human Genetics. 79 (5): 935–941. doi:10.1086/508433. ISSN   0002-9297. PMC   1698566 . PMID   17033969.
  6. "Kegg Disease: CATSHL syndrome". www.genome.jp. Retrieved 2022-05-15.
  7. 1 2 Toydemir, Reha M.; Brassington, Anna E.; Bayrak-Toydemir, Pınar; Krakowiak, Patrycja A.; Jorde, Lynn B.; Whitby, Frank G.; Longo, Nicola; Viskochil, David H.; Carey, John C.; Bamshad, Michael J. (2006-11-01). "A Novel Mutation in FGFR3 Causes Camptodactyly, Tall Stature, and Hearing Loss (CATSHL) Syndrome". The American Journal of Human Genetics. 79 (5): 935–941. doi:10.1086/508433. ISSN   0002-9297. PMC   1698566 . PMID   17033969.
  8. "Camptodactyly-Tall Stature-Scoliosis-Hearing Loss Syndrome". MalaCards. 2024-08-07. Retrieved 2024-08-11.
  9. "camptodactyly-tall stature-scoliosis-hearing loss syndrome Disease Ontology Browser - DOID:0111160". www.informatics.jax.org. Retrieved 2022-05-15.
  10. "Orphanet: Clinical signs and symptoms". www.orpha.net. Retrieved 2025-02-23.
  11. Deng, Chuxia; Wynshaw-Boris, Anthony; Zhou, Fen; Kuo, Ann; Leder, Philip (March 1996). "Fibroblast Growth Factor Receptor 3 Is a Negative Regulator of Bone Growth". Cell. 84 (6): 911–921. doi:10.1016/S0092-8674(00)81069-7. ISSN   0092-8674. Archived from the original on 2022-03-25.
  12. 1 2 Colvin, Jennifer S.; Bohne, Barbara A.; Harding, Gary W.; McEwen, Donald G.; Ornitz, David M. (April 1996). "Skeletal overgrowth and deafness in mice lacking fibroblast growth factor receptor 3" . Nature Genetics. 12 (4): 390–397. doi:10.1038/ng0496-390. ISSN   1546-1718.
  13. Escobar, Luis F.; Tucker, Megan; Bamshad, Michael (2016). "A second family with CATSHL syndrome: Confirmatory report of another unique FGFR3 syndrome" . American Journal of Medical Genetics Part A. 170 (7): 1908–1911. doi:10.1002/ajmg.a.37676. ISSN   1552-4833.
  14. Kim, Hwa Young; Ko, Jung Min (2022-06-30). "Clinical management and emerging therapies of FGFR3-related skeletal dysplasia in childhood". Annals of Pediatric Endocrinology & Metabolism. 27 (2): 90–97. doi:10.6065/apem.2244114.057. ISSN   2287-1012. PMC   9260370 . PMID   35793999.
  15. "Orphanet: Camptodactyly-tall stature-scoliosis-hearing loss syndrome". www.orpha.net. Retrieved 2025-02-23.